IL-6 increases airway resistance in the rat

Cytokine

Volumn 51, Issue 3, 2010, Pages 266-273

  Rubini, Alessandro ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

End inspiratory occlusion method; Interleukin 6; Respiratory mechanics

Indexed keywords

INTERLEUKIN 6;

AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ARTICLE; BREATHING MECHANICS; BREATHING RATE; COMPARTMENT MODEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HYSTERESIS; MALE; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT; RESPIRATORY AIRFLOW; RESPIRATORY SYSTEM; VISCOELASTICITY; ANIMAL; LUNG FUNCTION TEST; METABOLISM; PHYSIOLOGY; PRESSURE; TRACHEA; WISTAR RAT;

ANIMALIA; RATTUS;

AIRWAY RESISTANCE; ANIMALS; FEMALE; INTERLEUKIN-6; MALE; PRESSURE; RATS; RATS, WISTAR; RESPIRATORY MECHANICS; TRACHEA; WORK OF BREATHING;

EID: 77955271850     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.06.015     Document Type: Article

References (57)

1. Hardy R.D., Jafri H.S., Olsen K., Wordemann M., Hatfield J., Rogers B.B., et al. Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic and respiratory plethysmographic profile. Infect Immun 2001, 69:3869-3876.
2. Bergeron Y., Oullet N., Deslauriers M.A.M., Simard M., Olivier M., Bergeron M.G. Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infect Immun 1998, 66:912-922.
3. Nakamura T., Malloy J., McCaig L., Li-Juan Y., Mariamma J., Lewis J., et al. Mechanical ventilation of isolated septic rat lungs: effects on surfactant and inflammatory cytokines. J Appl Physiol 2001, 91:811-820.
4. Kline J.N., Cowden J.D., Hunninhake G.W., Schutte B.C., Watt J.L., Wohlford-Lenane C.L., et al. Variable airway responsiveness to inhaled lipopolysaccharide. Am J Respir Crit Care Med 1999, 160:297-303.
5. Kicic A., Sutanto E.N., Stevens P.T., Knight D.A., Stick S.M. Intrinsic biochemical and functional differences in bronchial epithelial cells of children with asthma. Am J Respir Crit Care Med 2006, 174:1110-1118.
6. Carpagnano G.E., Foschino Barbaro M.P., Resta O., Gramiccioni E., Valerio N.V., Bracciale P., et al. Exhaled markers in the monitoring of airways inflammation and its response to steroid's treatment in mild persistent asthma. Eur J Pharmacol 2005, 519:175-181.
7. Higashimoto Y., Yamagata Y., Taya S., Okada M., Ishiguchi T., Sato H., et al. Systemic inflammation in chronic obstructive pulmonary disease and asthma: similarities and differences. Respirology 2008, 13:128-133.
8. Taylor D.R. Risk assessment in asthma and COPD: a potential role for biomarkers?. Thorax 2009, 64:261-264.
9. Kuhn C., Homer R.J., Zhu Z., Ward N., Flavell R.A., Geba G.P., et al. Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung. Am J Respir Crit Care Med 2000, 22:289-295.
10. Nakamura T., Moyer B.Z., Veldhuizen R.A., Lewis J.F. Interleukin-6 has no effect on surfactant or lung function in different lung insults. Exp Lung Res 2006, 32:27-42.
11. Coussa M.L., Guerin C., Eissa N.T., Corbeil C., Chassè M., Braidy J., et al. Partitioning of work of breathing in mechanically ventilated COPD patients. J Appl Physiol 1993, 75:1711-1719.
12. D'Angelo E., Calderini E., Torri G., Robatto M., Bono D., Milic-Emili J. Respiratory mechanics in anesthetized paralyzed humans: effects of flow, volume and time. J Appl Physiol 1989, 67:2556-2564.
13. Bates J.H.T., Rossi A., Milic-Emili J. Analysis of the behaviour of the respiratory system with constant inspiratory flow. J Appl Physiol 1985, 58:1840-1848.
14. Bates J.H.T., Baconnier P., Milic-Emili J. A theoretical analysis of interrupter technique for measuring respiratory mechanics. J Appl Physiol 1988, 64:2204-2214.
15. Rubini A, Gasperetti A, Catena V, Del Monte D. The effect of acute blood volume expansion on respiratory mechanics in the rat. Respiration, doi:10.1159/000264924.
16. Peratoner A., Nascimento C.S., Santana M.C.E., Cadete R.A., Negri E.M., Gulla A., et al. Effects of propofol on respiratory mechanics and lung histology in normal rats. Br J Anaesth 2004, 92:737-740.
17. Buzello W., Diefenbach C., Nigrovic W. Muscle relaxants: a clinical update. Acta Anaesthesiol Scand Suppl 1996, 109:165-167.
18. Veldhuizen R.A., Slutsky A.S., Joseph M., McCaig L. Effects of mechanical ventilation of isolated mouse lungs on surfactant and inflammatory cytokines. Eur Respir J 2001, 17:488-494.
19. Tremblay L.N., Miatto D., Hamid Q., Govindarajan A., Slutsky A.S. Injurious ventilation induces widespread pulmonary epithelial expression of tumor necrosis factor-alpha and interleukin-6 messenger RNA. Crit Care Med 2002, 30:1693-1700.
20. Walder B., Fontao E., Totsch M., Morel D.R. Time and tidal volume-dependent ventilator-induced lung injury in healthy rats. Eur J Anaesthesiol 2005, 22:785-794.
21. Truwit J.D., Marini J.J. Evaluation of thoracic mechanics in the ventilated patients. Part 2: applied mechanics. J Crit Care 1988, 3:199-213.
22. Veldhuizen R.A.W., Welk B., Harbottle R., Heran S., Nag K., Petersen N., et al. Mechanical ventilation of isolated rat lungs changes the structure and biophysical properties of surfactant. J Appl Physiol 2002, 92:1169-1175.
23. Veldhuizen R.A., Tremblay R.N., Govindarajan A., van Rozendaal B.A., Haagsman H.P., Slustky A.S. Pulmonary surfactant is altered during mechanical ventilation of isolated rat lung. Crit Care Med 2000, 28:2545-2551.
24. Savale L., Tu L., Rideau D., Izziki M., Maitre B., Adnot S., et al. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice. Respir Res 2009, 27:10-16.
25. Selimovic N., Bergh C.H., Andesson B., Sakiniene E., Caristen H., Rundqvist B. Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension. Eur Respir J 2009, (Epub ahead of print).
26. Steiner M.K., Syrkina Ol., Kolliputi N., Mark E.J., Hales C.A., Waxman A.B. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 2009, 104:236-244.
27. Tsai B.M., Wang M., Pitcher J.M., Kher A., Meldrum D.R. Disparate IL-1beta and iNOS gene expression in the aorta and pulmonary artery after endotoxemia. Surg Infect 2006, 7:21-27.
28. Wang H., Lu X., Cao P.P., Chu Y., Long X.B., Zhang X.H., et al. Histological and immunological observations of bacterial and allergic chronic rhinosinusitis in the mouse. Am J Rhinol 2008, 22:343-348.
29. Min Y.G., Lee C.H., Rhee C.S., Hong S.K., Kwon S.H. Increased expression of IL-4, IL-5, IFN-gamma, IL-6, IL-8, and TGF-beta mRNAs in maxillary mucosa of patients with chronic sinusitis. Am J Rhinol 1999, 13:339-343.
30. Iwata S., Ito S., Iwaki M., Kondo M., Sashio T., Takeda N., et al. Regulation of endothelin-1-induced interleukin 6 production by CA2+ influx in human airway smooth muscle cells. Eur J Pharmacol 2009, 605:15-22.
31. Ammit A.J., Moir L.M., Oliver B.G., Hughes J.M., Alkhouri H., GE Q., et al. Effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2007, 292:L199-L206.
32. Mansour M., El-Hamady O., Motawi T. The priming effects of some human interleukins on the production of leukotrienes by calcium ionophore stimulated leukocytes. Biochem Mol Biol Int 1997, 42:817-824.
33. Lewis R.A., Austen K.F., Soberman R.J. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human disease. N Eng J Med 1990, 323:645-655.
34. Kirshenbaum A.S., Swindle E., Kulka M., Wu Y., Metcalfe D.D. Effect of lipopolysaccharide (LPS) and peptidoglycan (PGN) on human mast cell numbers, cytokines production, and protease composition. BMC Immunol 2008, 7:9-45.
35. Cairns J.A. Inhibitors of mast cells tryptase beta as therapeutics for the treatment of asthma and inflammatory disorders. Pulm Pharmacol Ther 2005, 18:55-66.
36. Chambers L.S., Black J.L., Poronnik P., Johnson P.R. Functional effects of protease-activated receptor-2 stimulation on human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2001, 281:1369-1378.
37. Schmidlin F., Amadesi S., Vidil R., Trevisani M., Martinet M., Caughey G., et al. Expression and function of proteinase-activated receptor 2 in human bronchial smooth muscle. Am J Respir Crit Care Med 2001, 164:1276-1281.
38. Barrios V.E., Jorosinski M.A., Wright C.D. Proteinase-activated receptor-2 mediates hyperresponsiveness in isolated guinea-pig bronchi. Biochem Pharmacol 2003, 66:519-525.
39. Lahiri T., Laporte J.D., Moore P.E., Panettieri R.A., Shore S.A. Interleukin-6 family cytokines: signaling and effects in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2001, 280:L1225-L1232.
40. Wang L., Pozzato V., Turato G., Madamanchi A., Murphy T.M., Chitano P. Reduced spontaneous relaxation in immature guinea pig airway smooth muscle is associated with increased prostanoid release. Am J Physiol Lung Cell Mol Physiol 2008, 294:L964-L973.
41. Eissa N.T., Ranieri V.M., Corbeil C., Chassè M., Robatto F.M., Braidy J., et al. Analysis of behaviour of respiratory system in ARDS patients: effects of flow, volume, and time. J Appl Physiol 1991, 70:2719-2729.
42. Tantucci C., Corbeil C., Chassè M., Robatto F.M., Nava S., Braidy J., et al. Flow and volume dependance of respiratory system flow resistance in patients with adult respiratory distress syndrome. Am Rev Respir Dis 1992, 145:355-360.
43. Guèrin C., Coussa M.L., Eissa N.T., Corbeil C., Chassè M., Braidy J., et al. Lung and chest wall mechanics in mechanically ventilated COPD patients. J Appl Physiol 1993, 74:1570-1580.
44. Fayon M., Rebola M., Berger P., Daburon S., Ousova O., Lavrand F., et al. Increased secretion of leukemia inhibitory factor by immature airway smooth muscle cells enhances intracellular signaling and airway contractility. Am J Physiol Lung Cell Mol Physiol 2006, 291:L244-L251.
45. Margulis A., Nocka K.H., Brennan A.M., Deng B., Fleming M., Goldman S.J., et al. Mast cell-dependent contraction of human airway smooth muscle cell-containing collagen gels: influence of cytokines, matrix metallo-proteases, and serine proteases. J Immunol 2009, 183:1739-1750.
46. Elias J.A., Wu Y., Zheng T., Panettieri R. Cytokine- and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines. Am J Physiol 1997, 273:L648-L655.
47. Damera G., Zhao H., Wang M., Smith M., Kirby C., Jester W.F., et al. Ozone modulates IL-6 secretion in human airway epithelial and smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2009, 296:L674-L683.
48. De S., Zelazny E.T., Souhrada J.F., Souhrada M. IL-1 beta and IL-6 induce hyperplasia and hypertrophy of cultured guinea pig airway smooth muscle cells. J Appl Physiol 1995, 78:1555-1563.
49. Quante T., Ng Y.C., Ramsay E.E., Henness S., Allen J.C., Parmentier J., et al. Corticosteroids reduce IL-6 in ASM cells via up-regulation of MKP-1. Am J Respir Cell Mol Biol 2008, 39:208-217.
50. Bates J.H.T., Hunter I.W., Sly P.D., Okubo S., Filiatrault S., Milic-Emili J. Effect of valve closure time on the determination of respiratory resistance by flow interruption. Med Biol Eng Comput 1987, 25:136-140.
51. Matsumoto T., Komori T., Yamamoto M., Shimada Y., Nakagawa M., Shiroyama T., et al. Prior intraperitoneal injection of rat recombinant IL-6 increases hypothalamic IL-6 contents in subsequent forced swim stressor in rats. Neuropsychobiology 2006, 54:186-194.
52. Song C., Merali Z., Anisman H. Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment. Neuroscience 1999, 88:823-836.
53. Zhang J., Terreni L., De Simoni M.G., Dunn A.J. Peripheral interleukin-6 administration increases extracellular concentrations of serotonin and the evoked release of serotonin in the rat striatum. Neurochem Int 2001, 38:303-308.
54. Bondì M., Cavaggioni A., Gasperetti A., Rubini A. A new method of measure of bubble gas volume shows that interleukin-6 injected into rats has no effect on gas embolism. Undersea Hyperb Med 2009, 36:103-110.
55. Febbraio M.A., Pedersen B.K. Muscle derived interleukin 6: mechanism for activation and possible biological role. FASEB J 2002, 16:1335-1347.
56. Gourine A.V., Poputnikov D.M., Zhernosek N., Melenchuk E.V., Gerstberger R., Spyer K.M., et al. P2 receptor blockade attenuates fever and cytokine responses induced by lipopolysaccharide in rats. Br J Pharmacol 2005, 146:139-145.
57. Shim J., Byun H.O., Lee Y.D., Lee E.S., Sohn S. Interleukin-6 small interfering RNA improved the herpes simplex virus-induced systemic inflammation in vivo Behecet's disease-like mouse model. Gene Ther 2008, (Epub ahead of print).